tetradecanoylphorbol acetate has been researched along with A-alphalipoprotein Neuropathy in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chin-Dusting, J; Hoang, A; McCormick, SP; Mukhamedova, N; Murphy, AJ; Remaley, AT; Stirzaker, RA; Sviridov, D; Woollard, KJ | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and A-alphalipoprotein Neuropathy
Article | Year |
---|---|
High-density lipoprotein reduces the human monocyte inflammatory response.
Topics: Actins; Apolipoprotein A-I; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; CD11b Antigen; Cell Adhesion; Cell Shape; Cells, Cultured; Cholesterol; Cyclodextrins; Endothelial Cells; Humans; Inflammation; Lipoproteins, HDL; Membrane Microdomains; Monocytes; Platelet Adhesiveness; Scavenger Receptors, Class B; Stress, Mechanical; Tangier Disease; Tetradecanoylphorbol Acetate; Time Factors | 2008 |